ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2310건의 자료가 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1603 | Completed | Covid-19, Hospitalized, PatIents, Nasafytol | Coronavirus Infection | Dietary Supplement: NASAFYTOL® Dietary Supplement: FULTIUM® -D3 800 Drug: Strandard of care treatment |
Not Applicable | Tilman S.A., Artialis | INDUSTRY | 51 | All | 18 Years | Delta Hospital, Brussels, Belgium |
| 1602 | Unknown status | COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1 | Pneumonia, Viral | Drug: Nivolumab | Phase 2 | Dr Gerry Gin Wai Kwok, The University of Hong Kong | OTHER | 15 | All | 18 Years | |
| 1601 | Withdrawn | COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older | Coronavirus Disease 2019 (COVID-19) | Biological: SARS-CoV-2 mRNA Vaccine (CVnCoV) Biological: Quadrivalent influenza vaccine (QIV) Other: Placebo |
Phase 3 | Bayer, CureVac | INDUSTRY | 0 | All | 60 Years | |
| 1600 | Completed | COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement | Transmission | Biological: BCG Biological: Placebo |
Phase 4 | University of Campinas, Brazil, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Paulinia Municipal Hospital | OTHER | 400 | All | 18 Years | Hospital das Clinicas Unicamp, Campinas, SP, Brazil |
| 1599 | Unknown status | COVID-19: Collecting Measurements of Renin-angiotensin-system Markers, Such as Angiotensin-2 and Angiotensin 1-7 | Covid19 | Combination Product: Tomeka® Drug: "Vernonia amygdalina" |
Not Applicable | Guyguy K Tshima, MD, Centre Medical de Kinshasa (CMK) | OTHER | 2000 | All | 15 Years ~ 65 Years | Cliniques Universitaires de Kinshasa, Kinshasa, Congo, The Democratic Republic of the |
| 1598 | Completed | COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients | SARS-CoV 2 | Drug: Povidone-Iodine Nasal Spray and Gargle Drug: Povidone-Iodine Nasal Spray and Gargle Drug: Povidone-Iodine Nasal Spray and Gargle |
Phase 2 | Nikita Gupta | OTHER | 98 | All | 18 Years ~ 99 Years | University of Kentucky, Lexington, Kentucky, United States |
| 1597 | Completed | COVID-19: Salvage TOcilizumab as a Rescue Measure | Covid19 | Drug: iv Tocillizumab (TCZ) | Phase 3 | Jarmo Oksi | OTHER_GOV | 88 | All | 18 Years | Turku University Hospital, Turku, Finland |
